Bruce Strober

58PUBLICATIONS
94CO-AUTHORS
Toxicology (incl. clinical toxicology)PharmacogenomicsClinical pharmacology and therapeuticsPsychopharmacologyMedical physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Oct 02, 2026
Efficacy of Apremilast in Patients with Psoriasis with Limited Skin Involvement, Including High-Impact Site Involvement: A Pooled Analysis of Six Trials.

|Aug 15, 2026
Characteristics of Real-World Patients with Psoriasis Receiving Guselkumab or Interleukin-17 Inhibitors: Data from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

|Aug 12, 2026
Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.

|Aug 07, 2026
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.

|Dec 05, 2025
Laboratory monitoring in patients with moderate to severe plaque psoriasis.

Jonathan M Fenkel, John A Osborne, April W Armstrong

|Nov 26, 2025
Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial.

Tadashi Terui, Yukari Okubo, Satomi Kobayashi

Pageof 10

Frequent Collaborators

10 joint publications

April W Armstrong

8 joint publications

Mark Lebwohl

7 joint publications

Kim Papp

6 joint publications

Richard B Warren